https://pioneervet.co.uk/categories/142/equipment?page=1Now on...

https://pioneervet.co.uk/categories/142/equipment?page=1

Now on offer with a Vet supply business in the UK (bottom of the page). I won't continue to update every time I see Petrackr come on line with a new distributor but it appears we are starting to see the product become available in the market.

When UBI next reports I would be interested in them providing some analysis of the revenue dynamics for each of their sub products. It appears that for Sentia and Xprecia, because of the high price of the handset, you get an initial burst of revenue from analyzer sales and then an extended shoulder period until the strip sales start to build up to the point where they become the dominant component of revenue. Or to put it another way in the first couple of years the revenue from analyser sales is significantly larger than from strips.

One might assume that given that the handset price is very much lower for Petrackr and that the handset volumes should be many multiples higher than for Sentia and Xprecia you should reach the point where strip sales are the dominant sources of revenue for Petrackr at a much earlier point.

To the extent the above analysis is correct or not, it would helpful to get management view on these dynamics when they next report.